Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
The use of non-coding RNAs (ncRNAs) as drug targets is being researched due to their discovery and their role in disease. Targeting ncRNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), is an attractive approach for treating various diseases, such as cardiovascular disease and can...
Main Author: | Francesco Nappi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/7/3630 |
Similar Items
-
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
by: Xiang Meng, et al.
Published: (2021-10-01) -
FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs
by: Mihnea P. Dragomir, et al.
Published: (2020-09-01) -
Editorial: Non-coding RNA in diabetes and cardiovascular diseases
by: Mirjana T. Macvanin, et al.
Published: (2023-02-01) -
Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
by: Yongting Lai, et al.
Published: (2019-11-01) -
Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
by: Yongting Lai, et al.
Published: (2020-03-01)